{
      "brief_title": [
            "study",
            "evaluate",
            "efficacy",
            "safety",
            "trastuzumab",
            "combination",
            "anastrozole",
            "aromatase",
            "inhibitor",
            "compare",
            "alone",
            "patient",
            "metastatic",
            "breast",
            "cancer"
      ],
      "brief_summary": [
            "2",
            "arm",
            "study",
            "ass",
            "safety",
            "efficacy",
            "add",
            "intravenous",
            "trastuzumab",
            "daily",
            "oral",
            "anastrozole",
            "tablet",
            "treatment",
            "postmenopausal",
            "patient",
            "human",
            "epidermal",
            "growth",
            "factor",
            "overexpressing",
            "metastatic",
            "breast",
            "cancer",
            "patient",
            "randomize",
            "receive",
            "either",
            "anastrazole",
            "1",
            "mg",
            "per",
            "o",
            "po",
            "daily",
            "anastrazole",
            "1",
            "mg",
            "po",
            "daily",
            "load",
            "dose",
            "4",
            "intravenous",
            "iv",
            "follow",
            "weekly",
            "dose",
            "2",
            "iv",
            "anticipate",
            "time",
            "study",
            "treatment",
            "disease",
            "progression",
            "target",
            "sample",
            "size",
            "individual"
      ],
      "condition": [
            "cancer"
      ],
      "intervention_type": [
            "Drug",
            "Drug"
      ],
      "intervention_name": [
            "trastuzumab (Herceptin\u00ae)",
            "anastrazole (Arimidex\u00ae)"
      ],
      "description": [
            "iv",
            "load",
            "dose",
            "follow",
            "iv",
            "weekly",
            "mg",
            "tablet",
            "take",
            "orally",
            "daily"
      ],
      "arm_group_label": [
            "anastrozole",
            "anastrozole"
      ],
      "other_name": [],
      "criteria": [
            "inclusion",
            "criterion",
            "postmenopausal",
            "woman",
            "metastatic",
            "breast",
            "cancer",
            "suitable",
            "endocrine",
            "therapy",
            "positive",
            "hormone",
            "receptor",
            "status",
            "human",
            "epidermal",
            "growth",
            "factor",
            "receptor",
            "2",
            "overexpression",
            "exclusion",
            "criterion",
            "patient",
            "hormone",
            "replacement",
            "therapy",
            "previous",
            "chemotherapy",
            "metastatic",
            "disease",
            "uncontrolled",
            "cardiac",
            "disease",
            "history",
            "cardiac",
            "failure"
      ],
      "gender": "Female",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "mesh_term": [
            "neoplasm",
            "inhibitor"
      ],
      "id": "NCT00022672"
}